Eosinophilic Duodenitis
📧 Sign up to get email alerts when something new happens for Eosinophilic Duodenitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have [Phase 2]
A Phase 2 study is evaluating dupilumab in adults and adolescents with eosinophilic gastritis with or without eosinophilic duodenitis (EGID)…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) [Phase 3]
Phase 3 extension study of lirentelimab in eosinophilic gastritis and eosinophilic duodenitis completed; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis [Phase 2]
An extension Phase 2 trial of AK002 in eosinophilic gastritis and/or eosinophilic duodenitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis [Phase 3]
Phase 3 trial of lirentelimab (AK002) in active eosinophilic duodenitis and eosinophilic gastroenteritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) [Phase 3]
Phase 3 trial evaluating AK002 in eosinophilic gastritis and eosinophilic duodenitis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2023-03-03Clinical Trial Update: A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis [Phase 3]
A Phase 3 trial evaluating subcutaneous AK002 for eosinophilic gastritis and/or eosinophilic duodenitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Effectiveness of Biofeedback-Assisted Relaxation Training in Children With Eosinophilic Duodenitis [NA]
A completed clinical trial evaluated the effectiveness of biofeedback-assisted relaxation training in children with eosinophilic duodenitis.